V022-3951 Screening compound: 5-[4-(2-methoxybenzamido)phenyl]-3-[(4-methylphenyl)methyl]-2-oxo-N-[(pyridin-3-yl)methyl]-1,3-oxazolidine-4-carboxamide

V022-3951 Screening compound: 5-[4-(2-methoxybenzamido)phenyl]-3-[(4-methylphenyl)methyl]-2-oxo-N-[(pyridin-3-yl)methyl]-1,3-oxazolidine-4-carboxamide
V022-3951 Screening compound: 5-[4-(2-methoxybenzamido)phenyl]-3-[(4-methylphenyl)methyl]-2-oxo-N-[(pyridin-3-yl)methyl]-1,3-oxazolidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V022-3951
5-[4-(2-methoxybenzamido)phenyl]-3-[(4-methylphenyl)methyl]-2-oxo-N-[(pyridin-3-yl)methyl]-1,3-oxazolidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V022-3951

Molecular Formula

C32H30N4O5 (C32 H30 N4 O5)

Compound Name

5-[4-(2-methoxybenzamido)phenyl]-3-[(4-methylphenyl)methyl]-2-oxo-N-[(pyridin-3-yl)methyl]-1,3-oxazolidine-4-carboxamide

IUPAC name

5-[4-(2-methoxybenzamido)phenyl]-3-[(4-methylphenyl)methyl]-2-oxo-N-[(pyridin-3-yl)methyl]-13-oxazolidine-4-carboxamide

SMILES

Cc1ccc(CN(C(C(c(cc2)ccc2NC(c(cccc2)c2OC)=O)O2)C(NCc3cnccc3)=O)C2=O)cc1

InChI

InChI=1S/C32H30N4O5/c1-21-9-11-22(12-10-21)20-36-28(31(38)34-19-23-6-5-17-33-18-23)29(41-32(36)39)24-13-15-25(16-14-24)35-30(37)26-7-3-4-8-27(26)40-2/h3-18,28-29H,19-20H2,1-2H3,(H,34,38)(H,35,37)

InChI Key

FDQHHSZEOGSGMI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19876715

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

550.61

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.427

Distribution Coefficient, logD

3.422

Water Solubility, LogSw

-3.48

Polar Surface Area

88.820

Acid Dissociation Constant (pKa)

9.81

Base Dissociation Constant (pKb)

5.15

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

18.80

V022-3951 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V022-3951 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V022-3951?
Check Price and Availability of V022-3951, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V022-3951 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V022-3951
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V022-3951
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V022-3951 available by request